KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Amortizatization of Intangibles: 2011-2024

Historic Amortizatization of Intangibles for Travere Therapeutics (TVTX) over the last 11 years, with Dec 2024 value amounting to $4.5 million.

  • Travere Therapeutics' Amortizatization of Intangibles rose 122.39% to $2.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.7 million, marking a year-over-year increase of 717.43%. This contributed to the annual value of $4.5 million for FY2024, which is 39.18% down from last year.
  • As of FY2024, Travere Therapeutics' Amortizatization of Intangibles stood at $4.5 million, which was down 39.18% from $7.5 million recorded in FY2023.
  • Travere Therapeutics' 5-year Amortizatization of Intangibles high stood at $7.5 million for FY2023, and its period low was -$2.0 million during FY2021.
  • Its 3-year average for Amortizatization of Intangibles is $4.2 million, with a median of $4.5 million in 2024.
  • Per our database at Business Quant, Travere Therapeutics' Amortizatization of Intangibles crashed by 189.21% in 2020 and then surged by 965.14% in 2023.
  • Travere Therapeutics' Amortizatization of Intangibles (Yearly) stood at -$703,000 in 2020, then tumbled by 185.63% to -$2.0 million in 2021, then soared by 134.86% to $700,000 in 2022, then spiked by 965.14% to $7.5 million in 2023, then plummeted by 39.18% to $4.5 million in 2024.